Zobrazeno 1 - 10
of 278
pro vyhledávání: '"J. Weeke"'
Autor:
S. E. Christensen, Kaal A, Jens Otto Lunde Jørgensen, E. Lund, H. Ørskov, J. Weeke, A.G. Harris
Publikováno v:
Metabolism. 41:44-50
Twenty-five acromegalic patients were studied during 6 years of treatment with octreotide, with a particular focus on the following parameters: (1) Administration schedule: in 10 patients, continuous subcutaneous (SC) octreotide infusion was compared
Publikováno v:
Global Journal of Environmental Science and Management, Vol 7, Iss 2, Pp 259-272 (2021)
BACKGROUND AND OBJECTIVES: Solid waste management which entails the generation, storage, collection, transportation, processing, treatment and disposal of waste products is regarded as a challenge to many countries worldwide. The focus and methods va
Externí odkaz:
https://doaj.org/article/638421c412274506b58372c978956ca2
Autor:
J, Lindholm, S, Juul, J O, Jørgensen, J, Astrup, P, Bjerre, U, Feldt-Rasmussen, C, Hagen, J, Jørgensen, M, Kosteljanetz, L, Kristensen, P, Laurberg, K, Schmidt, J, Weeke
Publikováno v:
The Journal of clinical endocrinology and metabolism. 86(1)
The main purpose was to assess the incidence and late outcome of Cushing's syndrome, particularly in Cushing's disease. Information for all patients diagnosed with Cushing's syndrome during an 11-yr period in Denmark was retrieved. The incidence was
Publikováno v:
Hormone and Metabolic Research. 24:237-239
The acute (TRH-stimulation test), intermediate (0-6 days administration), and long-term (0-30 months administration) effects of SMS 201-995 (octreotide) treatment on thyroid function were studied. Subcutaneous injection of 100 micrograms SMS 201-995
Autor:
Birgit Nyholm, Steven M. Pincus, C.H. Gravholt, J. Weeke, O. Schmitz, Johannes D. Veldhuis, Claus B. Juhl, Niels Pørksen, Peter C Butler
Publikováno v:
Metabolism: clinical and experimental. 49(7)
To examine beta-cell function in glucose-tolerant offspring of type 2 diabetic families, 41 insulin-resistant (hyperinsulinemic-euglycemic clamp, P < .001) first-degree relatives and 32 controls underwent oral (OGTT) and intravenous (IVGTT) glucose t
Autor:
H, Nørrelund, K Y, Hove, E, Brems-Dalgaard, A G, Jurik, L P, Nielsen, S, Nielsen, J O, Jørgensen, J, Weeke, N, Møller
Publikováno v:
Clinical endocrinology. 51(6)
Development of muscle weakness and atrophy are well known complications of thyrotoxicosis, although little is known about its clinical course. The present longitudinal study was therefore undertaken to monitor muscle mass and strength before and duri
Publikováno v:
Ugeskrift for laeger. 160(39)
In the period February 1994 to November 1995 11 laparoscopic adrenalectomies were performed at our institution (seven women, four men). A transperitoneal approach was used in both right- and left-sided operations. Results were collected retrospective
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(8)
Growth hormone (GH)-releasing peptides (GHRP) or secretagogs (GHS) constitute a family of synthetic compounds with potent and specific GH releasing activity. The receptor (GHS-R) has recently been cloned even though the endogenous ligand remains to b
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(4)
Increased proteolysis of insulin-like growth factor binding protein (IGFBP)-3 is seen in several pathophysiological conditions and may represent an important mechanism for the regulation of insulin-like growth factor bioavailability. It has previousl
Autor:
J, Weeke, H, Orskov, S E, Christensen, A, Kaal, C, Skjaerbaek, P, Illum, J, Jørgensen, E, Lund, A, Haubek, J H, Poulsen
Publikováno v:
Ugeskrift for laeger. 155(34)
We bring our experiences with and results of octreotide treatment for 0.5 to seven years in 26 highly selected acromegalic patients, i.e. they had almost all been operated upon before or were for other reasons not first-choice neurosurgical candidate